HBK Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,300
Closed -$895K 993
2020
Q4
$895K Sell
5,300
-9,600
-64% -$1.43M 0.01% 517
2020
Q3
$2.21M Hold
14,900
0.02% 347
2020
Q2
$2.45M Buy
+14,900
New +$2.29M 0.03% 275
2019
Q3
Sell
-184,700
Closed -$20.5M 702
2019
Q2
$20.5M Buy
184,700
+108,100
+141% +$12.7M 0.18% 44
2019
Q1
$9.94M Buy
+76,600
New +$9.31M 0.1% 173

Other funds holding LLY

HBK Investments's LLY Position: Q3 2023 in Review

HBK Investments sold out of Eli Lilly (LLY) in Q3 2023, closing a stake of 4,809 shares — an estimated $2.26M sold.

HBK Investments first reported a position in LLY in Q3 2013 and held it in 17 quarters. The position peaked at $17.2M in Q1 2018. 2,974 funds tracked by Wall St. Rank hold LLY as of Q3 2023.

  • HBK Investments reported no remaining Eli Lilly position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 4,809 Eli Lilly shares in Q3 2023, an estimated $2.26M.
  • HBK Investments first reported a position in Eli Lilly in Q3 2013 and held it in 17 quarters.
  • HBK Investments's Eli Lilly position peaked at $17.2M in Q1 2018.
  • 2,974 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.